» Articles » PMID: 38025979

Hormonal Contraception and Risk for Cognitive Impairment or Alzheimer's Disease and Related Dementias in Young Women: a Scoping Review of the Evidence

Overview
Specialty Public Health
Date 2023 Nov 29
PMID 38025979
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Women are significantly more likely to develop Alzheimer's disease and related dementias (ADRD) than men. Suggestions to explain the sex differences in dementia incidence have included the influence of sex hormones with little attention paid to date as to the effect of hormonal contraception on brain health. The aim of this scoping review is to evaluate the current evidence base for associations between hormonal contraceptive use by women and non-binary people in early adulthood and brain health outcomes.

Methods: A literature search was conducted using EMBASE, Medline and Google Scholar, using the keywords "hormonal contraception" OR "contraception" OR "contraceptive" AND "Alzheimer*" OR "Brain Health" OR "Dementia".

Results: Eleven papers were identified for inclusion in the narrative synthesis. Studies recruited participants from the UK, USA, China, South Korea and Indonesia. Studies included data from women who were post-menopausal with retrospective data collection, with only one study contemporaneously collecting data from participants during the period of hormonal contraceptive use. Studies reported associations between hormonal contraceptive use and a lower risk of ADRD, particularly Alzheimer's disease (AD), better cognition and larger grey matter volume. Some studies reported stronger associations with longer duration of hormonal contraceptive use, however, results were inconsistent. Four studies reported no significant associations between hormonal contraceptive use and measures of brain health, including brain age on MRI scans and risk of AD diagnosis.

Discussion: Further research is needed on young adults taking hormonal contraceptives, on different types of hormonal contraceptives (other than oral) and to explore intersections between sex, gender, race and ethnicity.

Systematic Review Registration: https://doi.org/10.17605/OSF.IO/MVX63, identifier: OSF.io: 10.17605/OSF.IO/MVX63.

Citing Articles

Hormone replacement therapy, menopausal age and lifestyle variables are associated with better cognitive performance at follow-up but not cognition over time in older-adult women irrespective of APOE4 carrier status and co-morbidities.

Watermeyer T, Gregory S, Leetham E, Udeh-Momoh C, Muniz-Terrera G Front Dement. 2025; 3:1496051.

PMID: 39897117 PMC: 11782126. DOI: 10.3389/frdem.2024.1496051.


Understanding Deep Endometriosis: From Molecular to Neuropsychiatry Dimension.

Pszczolowska M, Walczak K, Kolodziejczyk W, Kozlowska M, Kozlowski G, Gachowska M Int J Mol Sci. 2025; 26(2).

PMID: 39859551 PMC: 11765589. DOI: 10.3390/ijms26020839.


Leveraging research into sex differences and steroid hormones to improve brain health.

Lee B, Eid R, Hodges T, Barth C, Galea L Nat Rev Endocrinol. 2024; .

PMID: 39587332 DOI: 10.1038/s41574-024-01061-0.


Beyond Birth Control: The Neuroscience of Hormonal Contraceptives.

Lacasse J, Heller C, Kheloui S, Ismail N, Raval A, Schuh K J Neurosci. 2024; 44(40).

PMID: 39358019 PMC: 11450536. DOI: 10.1523/JNEUROSCI.1235-24.2024.


Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence.

Gregory S, Booi L, Jenkins N, Bridgeman K, Muniz-Terrera G, Farina F Front Glob Womens Health. 2023; 4:1289096.

PMID: 38025979 PMC: 10679746. DOI: 10.3389/fgwh.2023.1289096.

References
1.
Altmann A, Tian L, Henderson V, Greicius M . Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75(4):563-73. PMC: 4117990. DOI: 10.1002/ana.24135. View

2.
Peterson A, Tom S . A Lifecourse Perspective on Female Sex-Specific Risk Factors for Later Life Cognition. Curr Neurol Neurosci Rep. 2021; 21(9):46. PMC: 8449307. DOI: 10.1007/s11910-021-01133-y. View

3.
Dehlendorf C, Rodriguez M, Levy K, Borrero S, Steinauer J . Disparities in family planning. Am J Obstet Gynecol. 2010; 202(3):214-20. PMC: 2835625. DOI: 10.1016/j.ajog.2009.08.022. View

4.
Kim H, Yoo J, Han K, Lee D, Fava M, Mischoulon D . Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study. Alzheimers Res Ther. 2022; 14(1):83. PMC: 9202170. DOI: 10.1186/s13195-022-01026-3. View

5.
Lindseth L, de Lange A, van der Meer D, Agartz I, Westlye L, Tamnes C . Associations between reproductive history, hormone use, ε4 genotype and cognition in middle- to older-aged women from the UK Biobank. Front Aging Neurosci. 2023; 14:1014605. PMC: 9907169. DOI: 10.3389/fnagi.2022.1014605. View